NASDAQ:AXDX
Accelerate Diagnostics Stock News
$0.95
+0.0143 (+1.54%)
At Close: Apr 25, 2024
Global Medical Coatings (Active, Passive) Markets Report 2020-2025 - ResearchAndMarkets.com
12:00am, Friday, 18'th Sep 2020
The
Accelerate Diagnostics Announces Emergency Use Authorization for Covid-19 Antibody Test
02:30pm, Wednesday, 19'th Aug 2020
This new testing platform will speed up health checks by determining whether asymptomatic people have COVID-19 antibodies in 30 minutes.
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
11:32am, Wednesday, 19'th Aug 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) * Avenue Therapeutics Inc (NASDAQ: ATXI) * Checkmate Pharmaceuticals Inc (NASDAQ: CMPI) * DarioHealth Corp (NASDAQ: DRIO) * iTeos T
Accelerate Diagnostics Pops 10% On US Emergency Use Nod For Covid-19 Testing
07:58am, Wednesday, 19'th Aug 2020
Shares in Accelerate Diagnostics surged almost 10% in extended market trading after the company said the US Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its COVID-1
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System
08:15pm, Tuesday, 18'th Aug 2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, today announced that the U.S. Food and Drug Administration
Reata Slips On Update And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:RETA)
01:16pm, Tuesday, 11'th Aug 2020
Reata Slips on operational updates including omaveloxolone setback. Seelos receives FDA nod for Phase IIb/III trial.
Opdivo Plus Yervoy Demonstrates Durable Survival Benefit vs. Chemotherapy in Patients with Previously Untreated Malignant Pleural Mesothelioma
The Global Antimicrobial Susceptibility Testing Market will grow by USD 900.75 mn during 2020-2024
Global HIV Tests Market: Impact of COVID-19 for 2020 and Beyond - ResearchAndMarkets.com
12:00am, Thursday, 06'th Aug 2020
The
STERIS plc (STE) CEO Walter Rosebrough on Q1 2021 Results - Earnings Call Transcript
06:43pm, Tuesday, 04'th Aug 2020
STERIS plc (NYSE:STE) Q1 2021 Results Conference Call August 03, 2020 10:00 AM ET Company Participants Julie Winter - Investor Relations Walter Rosebrough - President and Chief Executive Officer Micha
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
04:33pm, Thursday, 30'th Jul 2020
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Puma Biotechnology's P 2 SUMMIT trial results of neratinib in HER2-Mutant, metastatic cervical cancers were published online in Gynecologic Oncology.
